Exhaled Mycobacterium tuberculosis Predicts Incident Infection in Household Contacts

Clin Infect Dis. 2023 Feb 8;76(3):e957-e964. doi: 10.1093/cid/ciac455.

Abstract

Background: Halting transmission of Mycobacterium tuberculosis (Mtb) by identifying infectious individuals early is key to eradicating tuberculosis (TB). Here we evaluate face mask sampling as a tool for stratifying the infection risk of individuals with pulmonary TB (PTB) to their household contacts.

Methods: Forty-six sputum-positive PTB patients in The Gambia (August 2016-November 2017) consented to mask sampling prior to commencing treatment. Incident Mtb infection was defined in 181 of their 217 household contacts as QuantiFERON conversion or an increase in interferon-γ of ≥1 IU/mL, 6 months after index diagnosis. Multilevel mixed-effects logistical regression analysis with cluster adjustment by household was used to identify predictors of incident infection.

Results: Mtb was detected in 91% of PTB mask samples with high variation in IS6110 copies (5.3 × 102 to 1.2 × 107). A high mask Mtb level (≥20 000 IS6110 copies) was observed in 45% of cases and was independently associated with increased likelihood of incident Mtb infection in contacts (adjusted odds ratio, 3.20 [95% confidence interval, 1.26-8.12]; P = .01), compared with cases having low-positive/negative mask Mtb levels. Mask Mtb level was a better predictor of incident Mtb infection than sputum bacillary load, chest radiographic characteristics, or sleeping proximity.

Conclusions: Mask sampling offers a sensitive and noninvasive tool to support the stratification of individuals who are most infectious in high-TB-burden settings. Our approach can provide better insight into community transmission in complex environments.

Keywords: exhaled breath; face mask sampling; infectiousness; transmission; tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interferon-gamma
  • Mycobacterium tuberculosis*
  • Sputum / microbiology
  • Tuberculosis* / complications
  • Tuberculosis* / diagnosis
  • Tuberculosis* / epidemiology
  • Tuberculosis, Pulmonary* / complications
  • Tuberculosis, Pulmonary* / diagnosis
  • Tuberculosis, Pulmonary* / epidemiology

Substances

  • Interferon-gamma